Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multidisciplinary telemedicine intervention for ICU recovery: the TelePORT feasibility randomized trial.

Critical care (London, England)·2026
Same author

17th Annual University of Pennsylvania Conference on statistical issues in clinical trials - Covariate adjustment in randomized clinical trials: New methods and applications (Afternoon panel discussion).

Clinical trials (London, England)·2026
Same author

How Much is Enough? Refining Pragmatic Trial Design for Antimicrobial Stewardship.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Determining the Physiological Threshold for Angina (ORBITA-FIRE): A Double-Blind, Randomized, Placebo-Controlled Study.

Circulation·2026
Same author

Community consultation and public disclosure for the Randomized Trial of Sedative Choice for Intubation.

Trials·2026
Same author

Evaluation of the impact of universal mupirocin decolonization in intensive care units on the utility of MRSA PCR nasal swab testing.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Related Experiment Video

Updated: Jun 3, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Swab Testing to Optimize Pneumonia Treatment With Empiric Vancomycin: A Randomized Controlled Trial.

Jeffrey A Freiberg1,2,3,4, Edward T Qian5,6,7, Kylie G Nairon8

  • 1Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|June 2, 2026
PubMed
Summary

Methicillin-resistant Staphylococcus aureus (MRSA) PCR nasal swab testing did not reduce vancomycin use in ICU patients with suspected pneumonia. This study highlights the need for enhanced antimicrobial stewardship for effective vancomycin de-escalation.

Keywords:
Staphylococcus aureusICUMRSA nasal colonizationantimicrobial stewardshipcommunity-acquired pneumonia

Related Experiment Videos

Last Updated: Jun 3, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Clinical Microbiology

Background:

  • Fear of methicillin-resistant Staphylococcus aureus (MRSA) often leads to empiric vancomycin use for community-acquired pneumonia (CAP).
  • Limited data exists on using MRSA PCR nasal swab testing to guide vancomycin de-escalation in intensive care unit (ICU) patients.

Purpose of the Study:

  • To evaluate the effectiveness of MRSA PCR nasal swab testing in guiding vancomycin de-escalation for ICU patients with suspected CAP.
  • To assess the impact of MRSA PCR testing on vancomycin-free hours alive and 30-day mortality.

Main Methods:

  • A randomized trial (STOP-Vanc) involving 277 adult ICU patients with suspected CAP.
  • Patients were randomized to usual care with or without MRSA nares PCR testing.
  • The primary outcome was vancomycin-free hours alive within the first 7 days.

Main Results:

  • MRSA PCR nasal swab testing demonstrated a high negative predictive value (98.9%) in the intervention arm.
  • No significant difference was found in vancomycin-free hours alive between the control (105.7 hours) and intervention (109.7 hours) groups.
  • The study did not show a decrease in vancomycin use duration or 30-day mortality.

Conclusions:

  • MRSA PCR nasal swab testing, despite high NPV, did not reduce vancomycin duration or mortality in critically ill patients with suspected CAP.
  • Additional interventions, such as clinician education and antimicrobial stewardship, may be necessary to optimize vancomycin use.